Cargando…
TrkA Co-Receptors: The Janus Face of TrkA?
SIMPLE SUMMARY: NGF was the first growth factor discovered by Rita Levi Montalcini in 1950. TrkA, its high affinity receptor, is an oncogene that is overexpressed in many cancers. However, targeted therapies against TrkA, in particular kinase inhibitors, have not yet demonstrated efficacy in the con...
Autores principales: | Trouvilliez, Sarah, Lagadec, Chann, Toillon, Robert-Alain |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093326/ https://www.ncbi.nlm.nih.gov/pubmed/37046604 http://dx.doi.org/10.3390/cancers15071943 |
Ejemplares similares
-
Direct interaction of TrkA/CD44v3 is essential for NGF-promoted aggressiveness of breast cancer cells
por: Trouvilliez, Sarah, et al.
Publicado: (2022) -
NGF – the TrkA to successful pain treatment
por: Kumar, Vinayak, et al.
Publicado: (2012) -
Combinatorial Assembly of Small Molecules into Bivalent Antagonists of TrkC or TrkA Receptors
por: Brahimi, Fouad, et al.
Publicado: (2014) -
NGF-induced TrkA/CD44 association is involved in tumor aggressiveness and resistance to lestaurtinib
por: Aubert, Léo, et al.
Publicado: (2015) -
Transcytosis of TrkA leads to diversification of dendritic signaling endosomes
por: Barford, Kelly, et al.
Publicado: (2018)